The core technology owned by AM BioTech Co., Ltd., in addition to the professional separation and cultivation of various stem cell technologies and the exclusive patented biochemical pulse activation technology, and the exclusive patent for the secretion of stem cells after being activated by biochemical pulses Extraction and purification technology of exosomes.
This technology has been applied for patents in Taiwan, the United States, the European Union, Japan, China and other countries. At present, the establishment of a GMP-level factory in Taiwan has been completed and the future layout in mainland China has been started.